A review on the treatment of relapsed/metastatic head and neck cancer

The efficacy of traditional chemotherapy in inducing objective responses and prolonging survival in recurrent or metastatic head and neck cancer has been disappointing. More recent drugs have not proven superior to the classic regimen of cisplatin and 5-fluorouracil. Anti-EGFR monoclonal antibodies,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Expert opinion on pharmacotherapy 2009-11, Vol.10 (16), p.2625-2632
Hauptverfasser:	Ferrari, Daris, Codecà, Carla, Fiore, Jessica, Luciani, Andrea, Foa, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use biological agents cetuximab chemotherapy Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - pathology Humans metastatic head and neck cancer Neoplasm Metastasis Protein Kinase Inhibitors - therapeutic use Recurrence targeted therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!